MusclePharm is a nutritional supplement company, who has been consistently reporting strong revenue growth over the past few years. The stock has made a significant move up since the 2nd week in march, moving from well under a penny to close to $0.04 before dropping back down to current levels. MSLP is currently trading at $0.016
MusclePharm is a rapidly expanding healthy life-style company that developed and manufactures a full line of NSF and scientifically approved nutritional supplements that are 100% free of any banned substances. Headquartered in Denver, Colorado, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists, and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. The Company's products address muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail as well as 100 online stores. It is important to note that MSLP products are gaining popularity at an incredible rate and its fast growing user base swears by the products.
Despite a rapidly growing product line and continued revenue growth, over the past few years MSLP has been plagued by high administration expenses and a high debt burden which has resulted in massive dilution. In fact, continued dilution has been the primary factor keeping MSLP so cheap for years.
Over the past month, MSLP has made some important announcements. They announced 1st quarter 2012 revenues of over $19M, a 400% increase from the year before. This is no ordinary penny stock, if the company can finally get the share structure cleaned up, MSLP could be one of the biggest stocks of the year and it certainly look like the Company is planning to do just that; They recently completed the retirement of all outstanding convertible notes held by various financing companies. Specifically, Muscle Pharm Corporation has retired $5.5 million of derivative financing instruments with $3 million cash and 55 million shares of common stock and to top that off they recently announced a 100M share buyback program on the open market.
Any company that trades on the OTCBB and does $19M in revenues a quarter deserves the attention of investors, the bottom line is MSLP makes great products that people love and they are quickly becoming a major player in the multi-billion health supplemental sector, once the stock is cleaned up, and it looks like they are working on doing just that, MSLP could be a huge runner. We will be releasing more articles on MSLP as news develops and this exciting story unfolds.
So Please subscribe to OTCMagic right now. We are an awesome newsletter that provides commentary on anything big and exciting that's happening on the bb's, if you are not subscribed yet, please do so immediately, unlike everyone else, we tell it exactly like it is.
OTCMagic.com is an awesome newsletter focused on penny stocks and stock picks
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.